Interacciones medicamentosas de etravirina
Etravirine drug interactions
Vicente Estrada Pérez
, Clara Sánchez-Parra, Sergio Serrano Villar
Autor para correspondencia
Unidad de Enfermedades Infecciosas/VIH, Servicio de Medicina Interna, Hospital Clínico San Carlos, Madrid, España
Leído
3051
Vecesse ha leído el artículo
1031
Total PDF
2020
Total HTML
Compartir estadísticas
array:23 [ "pii" => "S0213005X09732161" "issn" => "0213005X" "doi" => "10.1016/S0213-005X(09)73216-1" "estado" => "S300" "fechaPublicacion" => "2009-12-01" "aid" => "73216" "copyright" => "Elsevier España S.L.. Todos los derechos reservados" "copyrightAnyo" => "2009" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Enferm Infecc Microbiol Clin. 2009;27 Supl 2:27-31" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2164 "formatos" => array:3 [ "EPUB" => 8 "HTML" => 1499 "PDF" => 657 ] ] "itemSiguiente" => array:18 [ "pii" => "S0213005X09732173" "issn" => "0213005X" "doi" => "10.1016/S0213-005X(09)73217-3" "estado" => "S300" "fechaPublicacion" => "2009-12-01" "aid" => "73217" "copyright" => "Elsevier España S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Enferm Infecc Microbiol Clin. 2009;27 Supl 2:32-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3276 "formatos" => array:3 [ "EPUB" => 9 "HTML" => 2325 "PDF" => 942 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Etravirina: barrera genética y desarrollo de resistencias" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "32" "paginaFinal" => "39" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Etravirine: genetic barrier and resistance development" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Josep M. Llibre, José Ramón Santos, Bonaventura Clotet" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Josep M." "apellidos" => "Llibre" ] 1 => array:2 [ "nombre" => "José Ramón" "apellidos" => "Santos" ] 2 => array:2 [ "nombre" => "Bonaventura" "apellidos" => "Clotet" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X09732173?idApp=UINPBA00004N" "url" => "/0213005X/00000027000000S2/v1_201305090145/S0213005X09732173/v1_201305090145/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0213005X0973215X" "issn" => "0213005X" "doi" => "10.1016/S0213-005X(09)73215-X" "estado" => "S300" "fechaPublicacion" => "2009-12-01" "aid" => "73215" "copyright" => "Elsevier España S.L." "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Enferm Infecc Microbiol Clin. 2009;27 Supl 2:21-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1846 "formatos" => array:3 [ "EPUB" => 8 "HTML" => 1404 "PDF" => 434 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Seguridad y tolerabilidad de etravirina" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "21" "paginaFinal" => "26" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Safety and tolerability of etravirine" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Joaquín Portilla" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Joaquín" "apellidos" => "Portilla" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X0973215X?idApp=UINPBA00004N" "url" => "/0213005X/00000027000000S2/v1_201305090145/S0213005X0973215X/v1_201305090145/es/main.assets" ] "es" => array:12 [ "idiomaDefecto" => true "titulo" => "Interacciones medicamentosas de etravirina" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "27" "paginaFinal" => "31" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Vicente Estrada Pérez, Clara Sánchez-Parra, Sergio Serrano Villar" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Vicente Estrada" "apellidos" => "Pérez" "email" => array:1 [ 0 => "vestrada.hcsc@salud.madrid.org" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor1" ] ] ] 1 => array:2 [ "nombre" => "Clara" "apellidos" => "Sánchez-Parra" ] 2 => array:2 [ "nombre" => "Sergio Serrano" "apellidos" => "Villar" ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Unidad de Enfermedades Infecciosas/VIH, Servicio de Medicina Interna, Hospital Clínico San Carlos, Madrid, España" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "⁎" "correspondencia" => "Autor para correspondencia." ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Etravirine drug interactions" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec137943" "palabras" => array:2 [ 0 => "Etravirina" 1 => "Interacciones" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec137944" "palabras" => array:2 [ 0 => "Etravirine" 1 => "Drug interactions" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<p class="elsevierStyleSimplePara elsevierViewall">Etravirina (ETR) es un fármaco perteneciente a la familia de los inhibidores de la transcriptasa inversa no análogos de nucleósidos (ITINAN), con actividad antiviral en situaciones de resistencia a los ITINAN de primera generación. Las interacciones farmacológicas producidas por ETR se deben a su efecto dual sobre el sistema CYP450. Es inductor de la actividad de CYP3A4 e inhibidor de la de CYP2C9 y CYP2C19. ETR presenta escasas interacciones farmacológicas clínicamente significativas, entre las que destacan los inhibidores de la proteasa sin potenciar, los ITINAN efavirenz y nevirapina, ritonavir a dosis plena y tipranavir/ritonavir. La interacción con fosamprenavir/ritonavir no es clínicamente significativa, aunque hay una escasa variación de sus valores plasmáticos al administrarse de manera conjunta con ETR. No presenta interacciones con darunavir/ritonavir.</p>" ] "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<p class="elsevierStyleSimplePara elsevierViewall">Etravirine (ETR) belongs to the family of non-nucleoside analogue reverse transcriptase inhibitors (NNRTIs), with antiviral activity in patients with resistance to first-generation NNRTIs. The drug interactions caused by ETR are due to its dual effect on the CYP450 system. ETR acts as an inducer of CYP3A4 and inhibitor of CYP2C9 and CYP2C19. This drug shows few clinically significant drug interactions, the most important of which involve the unboosted protease inhibitors, the NNRTIs efavirenz and nevirapine, full-dose ritonavir and tipranavir/ritonavir. Interaction with fosamprenavir/ritonavir is not clinically significant, although their plasma levels vary slightly when used in combination with ETR. ETR shows no interactions with darunavir/ritonavir.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:29 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Etravirine: a second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.S. Schiller" 1 => "M. Youssef-Bessler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.clinthera.2009.04.020" "Revista" => array:6 [ "tituloSerie" => "Clin Ther" "fecha" => "2009" "volumen" => "31" "paginaInicial" => "692" "paginaFinal" => "704" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19446143" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Informe público europeo de evaluación (EPAR), Intelence European Medicines Agency (EMEA). Documento EMEA/H/C/900 [consultado 14-7-2009]. Disponible en: <a class="elsevierStyleInterRef" href="http://www.emea.europa.eu/">http://www.emea.europa.eu</a>" ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mass-balance of 14C-labelled TMC125 in healthy volunteers" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Schöller-Gyre" 1 => "A. Raaof" 2 => "G. Mannens" 3 => "S. Bollen" 4 => "T.N. Kakuda" 5 => "D. Woodfall" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "8th International Workshop on Clinical Pharmacology of HIV Therapy" "conferencia" => "Budapest" "serieFecha" => "2007" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Drug interactions with TMC125, a Potent Next Generation NNRTI" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "P. Baede" 1 => "S. Piscitelli" 2 => "N. Graham" 3 => "G. Van’t Klooster" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "Program and abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy" "conferencia" => "San Diego. September 27-30" "serieFecha" => "2002" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "No significant interaction between TMC125 and didanosine in healthy volunteers" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Schöller-Gyre" 1 => "R. Hoetelmans" 2 => "S. Bollen" 3 => "K. Vandermeulen" 4 => "M. Peeters" 5 => "L. Bastiaanse" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "3rd International AIDS Society Conference on HIV Pathogenesis and Treatment" "conferencia" => "Rio de Janeiro" "serieFecha" => "2005" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetic evaluation of the interaction between TMC125 and tenofovir disoproxil fumarate" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Schöller-Güyre" 1 => "C. Debroye" 2 => "B. Woodfall" 3 => "J. Witek" 4 => "G. De Smedt" 5 => "R.M. Hoetelmans" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "46th Interscience Conference on Antimicrobial Agents and Chemotherapy" "conferencia" => "San Francisco (CA)" "serieFecha" => "2006" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TMC125 in combination with other medications: summary of drug-drug interaction studies" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Kakuda" 1 => "M. Schöller-Gyüre" 2 => "B. Woodfall" 3 => "G. De Smedt" 4 => "M. Peeters" 5 => "K. Vandermeulen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "8th International Congress on Drug Therapy in HIV Infection" "conferencia" => "Glasgow. 12-16 November" "serieFecha" => "2006" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetics and safety of adding TMC125 to stable regimens of saquinavir, lopinavir and ritonavir in HIV+adults" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Harris" 1 => "C. Zala" 2 => "S. Ramírez" 3 => "B. Woodfall" 4 => "M. Peeters" 5 => "M. Scholler" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "13th Conference on Retroviruses and Opportunistic Infections" "conferencia" => "Denver (CO). 5-8 Feb" "serieFecha" => "2006" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetics of TMC125 with atazanavir and atazanavir/ritonavir" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Schöller Gyüre" 1 => "B. Woodffall" 2 => "T. De Marez" 3 => "G. De Smedt" 4 => "M. Peeters" 5 => "K. Vandermeulen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "8th Internacional Congress on Drug Therapy in HIV Infection" "conferencia" => "Glasgow. Nov 12-16" "serieFecha" => "2006" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Significant decrease in TMC125 exposures when co-administered with tipranavir in healthy subjects" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Schöller" 1 => "M. Kraft" 2 => "R. Hoetelmans" 3 => "V. Vyncke" 4 => "K. Vandermeulen" 5 => "M. Peeters" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "13th Conference on Retroviruses and Opportunistic Infections" "conferencia" => "Denver (CO). 5-8 Feb" "serieFecha" => "2006" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetics of amprenavir and TMC125 in HIV infected volunteers receiving TMC125 with fosamprenavir/ritonavir" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Schöller-Gyüre" 1 => "B. Woodfall" 2 => "S. Bollen" 3 => "M. Peeters" 4 => "K. Vandermeulen" 5 => "R. Hoetelmans" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "46th Interscience Conference on Antimicrobial Agents and Chemotherapy" "conferencia" => "San Francisco (CA)" "serieFecha" => "2006" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TMC125 does not alter lopinavir/ritonavir pharmacokinetics in healthy volunteers" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S.C. Piscitelli" 1 => "P. Baede" 2 => "G. Van’t Klooster" 3 => "N. Graham" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "42nd Interscience Conference on Antimicrobial Agents and Chemotherapy" "conferencia" => "San Diego (CA)" "serieFecha" => "2002" ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetic interaction between etravirine and lopinavir/ritonavir" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Schöller-Gyüre" 1 => "T.N. Kakuda" 2 => "S.H. Akuma" 3 => "I. De Clero" 4 => "G. De Smedt" 5 => "K. Spittaels" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)" "conferencia" => "San Francisco, California, USA. September" "serieFecha" => "2009" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Lazzarin" 1 => "T. Campbell" 2 => "B. Clotet" 3 => "M. Johnson" 4 => "C. Katlama" 5 => "A. Moll" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(07)61048-4" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2007" "volumen" => "370" "paginaInicial" => "39" "paginaFinal" => "48" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17617271" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.V. Madruga" 1 => "P. Cahn" 2 => "B. Grinsztejn" 3 => "R. Haubrich" 4 => "J. Lalezari" 5 => "A. Mills" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(07)61047-2" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2007" "volumen" => "370" "paginaInicial" => "29" "paginaFinal" => "38" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17617270" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetics of darunavir/ritonavir and TMC125 alone and coadministered in HIV-negative volunteers" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Schöller-Gyüre" 1 => "T.N. Kakuda" 2 => "V. Sekar" 3 => "B. Woodfall" 4 => "G. De Smedt" 5 => "E. Lefebvre" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Antivir Ther" "fecha" => "2007" "volumen" => "12" "paginaInicial" => "789" "paginaFinal" => "796" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17713162" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetics of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Lalezari" 1 => "E. DeJesus" 2 => "O. Osiyemi" 3 => "P. Ruane" 4 => "Z. Haigney" 5 => "R. Ryan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "9th International Congress on Drug Therapy in HIV Infection" "conferencia" => "Glasgow. November 9-13" "serieFecha" => "2008" ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An open, randomized, two period, crossover study in 2 cohorts to investigate the effect of steady state TMC125 and the combination of TMC/darunavir/ritonavir on the steady state pharmacokinetics of oral maraviroc in healthy subjects" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Davis" 1 => "M. Schöller-Gyre" 2 => "T.N. Kakuda" 3 => "C. Ridgway" 4 => "S. Tweedy" 5 => "N. Ndongo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "11th European AIDS Conference" "conferencia" => "Madrid, Spain. Oct 24-27" "serieFecha" => "2007" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Etravirine-raltegravir, a marked interaction in HIV-1 infected patients: about four cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Menard" 1 => "C. Solas" 2 => "S. Mokthari" 3 => "S. Bregigeon" 4 => "M.P. Drogoul" 5 => "C. Tamalet" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/QAD.0b013e3283262aa0" "Revista" => array:6 [ "tituloSerie" => "AIDS" "fecha" => "2009" "volumen" => "23" "paginaInicial" => "869" "paginaFinal" => "871" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19363332" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Minimal pharmacokinetic interaction between the human immunodeficiency virus non-nucleoside reverse transcriptase inhibitor etravirine and the integrase inhibitor raltegravir in healthy subjects" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.S. Anderson" 1 => "T.N. Kakuda" 2 => "W. Hanley" 3 => "J. Miller" 4 => "J.T. Kost" 5 => "R. Stoltz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/AAC.00487-08" "Revista" => array:6 [ "tituloSerie" => "Antimicrob Agents Chemother" "fecha" => "2008" "volumen" => "52" "paginaInicial" => "4228" "paginaFinal" => "4232" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18838586" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Wittkop" 1 => "D. Breilh" 2 => "D. Da Silva" 3 => "P. Duffau" 4 => "P. Mercié" 5 => "I. Raymond" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/jac/dkp114" "Revista" => array:6 [ "tituloSerie" => "J Antimicrob Chemother" "fecha" => "2009" "volumen" => "63" "paginaInicial" => "1251" "paginaFinal" => "1255" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19336453" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetics of elvitegravir and etravirine following coadministration of ritonavir-boosted elvitegravir and etravirine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S. Ramanathan" 1 => "T.N. Kakuda" 2 => "R. Mack" 3 => "S. West" 4 => "B.P. Kearney" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Antivir Ther" "fecha" => "2008" "volumen" => "13" "paginaInicial" => "1011" "paginaFinal" => "1017" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19195326" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetic interaction between TMC125 and rifabutin" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Schöller-Gyüre" 1 => "B. Woodfall" 2 => "C. Debroye" 3 => "T. De Marez" 4 => "M. Peeters" 5 => "K. Vandermeulen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "44th Annual Meeting of the Infectious Diseases Society of America" "conferencia" => "Toronto. 12-15 Oct" "serieFecha" => "2006" ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Etravirine interactions chart [consultado 14-7-2009]. Disponible en: <a class="elsevierStyleInterRef" href="http://www.hiv-druginteractions.org/">http://www.hiv-druginteractions.org</a>" ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetic and pharmacodynamic study of the concomitant administration of methadone and TMC125 in HIV-negative volunteers" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Schöller-Gyüre" 1 => "W. Van den Brink" 2 => "T.N. Kakuda" 3 => "B. Woodfall" 4 => "G. De Smedt" 5 => "H. Vanaken" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0091270007310387" "Revista" => array:6 [ "tituloSerie" => "J Clin Pharmacol" "fecha" => "2008" "volumen" => "48" "paginaInicial" => "322" "paginaFinal" => "329" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18195053" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetic interaction between the non-nucleoside reverse transcriptase inhibitor TMC125 and atorvastatin in HIV-negative volunteers" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Schöller-Gyüre" 1 => "T.N. Kakuda" 2 => "G. De Smedt" 3 => "B. Woodfall" 4 => "S. Bollen" 5 => "M. Peeters" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention" "conferencia" => "Sydney. 22-25 Jul" "serieFecha" => "2007" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib27" "etiqueta" => "27." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Etravirine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "I.D. Deeks" 1 => "G.M. Keating" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Drugs" "fecha" => "2008" "volumen" => "68" "paginaInicial" => "2357" "paginaFinal" => "2372" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18973398" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib28" "etiqueta" => "28." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Schöller-Gyüre" 1 => "T.N. Kakuda" 2 => "G. De Smedt" 3 => "H. Vanaken" 4 => "M.P. Bouche" 5 => "M. Peeters" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Br J Pharmacol" "fecha" => "2008" "volumen" => "66" "paginaInicial" => "508" "paginaFinal" => "516" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib29" "etiqueta" => "29." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TMC125 in combination with other medications: summary of drug-drug interaction studies" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Kakuda" 1 => "M. Schöller-Gyüre" 2 => "B. Woodfall" 3 => "G. De Smedt" 4 => "M. Peeters" 5 => "K. Vandermeulen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "8th International Congress on Drug Therapy in HIV Infection" "conferencia" => "Glasgow. 12-16 November" "serieFecha" => "2006" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/0213005X/00000027000000S2/v1_201305090145/S0213005X09732161/v1_201305090145/es/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/0213005X/00000027000000S2/v1_201305090145/S0213005X09732161/v1_201305090145/es/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X09732161?idApp=UINPBA00004N" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Octubre | 7 | 4 | 11 |
| 2024 Septiembre | 17 | 4 | 21 |
| 2024 Agosto | 9 | 3 | 12 |
| 2024 Julio | 11 | 5 | 16 |
| 2024 Junio | 10 | 7 | 17 |
| 2024 Mayo | 4 | 2 | 6 |
| 2024 Abril | 15 | 5 | 20 |
| 2024 Marzo | 13 | 4 | 17 |
| 2024 Febrero | 3 | 3 | 6 |
| 2024 Enero | 8 | 4 | 12 |
| 2023 Diciembre | 7 | 1 | 8 |
| 2023 Noviembre | 8 | 3 | 11 |
| 2023 Octubre | 11 | 1 | 12 |
| 2023 Septiembre | 10 | 2 | 12 |
| 2023 Agosto | 8 | 1 | 9 |
| 2023 Julio | 3 | 3 | 6 |
| 2023 Junio | 11 | 1 | 12 |
| 2023 Mayo | 7 | 1 | 8 |
| 2023 Abril | 5 | 1 | 6 |
| 2023 Marzo | 7 | 10 | 17 |
| 2023 Febrero | 4 | 2 | 6 |
| 2023 Enero | 5 | 4 | 9 |
| 2022 Diciembre | 6 | 15 | 21 |
| 2022 Noviembre | 8 | 14 | 22 |
| 2022 Octubre | 9 | 10 | 19 |
| 2022 Septiembre | 9 | 23 | 32 |
| 2022 Agosto | 11 | 10 | 21 |
| 2022 Julio | 7 | 9 | 16 |
| 2022 Junio | 8 | 5 | 13 |
| 2022 Mayo | 22 | 7 | 29 |
| 2022 Abril | 8 | 11 | 19 |
| 2022 Marzo | 23 | 18 | 41 |
| 2022 Febrero | 29 | 2 | 31 |
| 2022 Enero | 27 | 8 | 35 |
| 2021 Diciembre | 10 | 12 | 22 |
| 2021 Noviembre | 7 | 13 | 20 |
| 2021 Octubre | 8 | 12 | 20 |
| 2021 Septiembre | 7 | 10 | 17 |
| 2021 Agosto | 8 | 13 | 21 |
| 2021 Julio | 6 | 3 | 9 |
| 2021 Junio | 4 | 12 | 16 |
| 2021 Mayo | 14 | 5 | 19 |
| 2021 Abril | 14 | 13 | 27 |
| 2021 Marzo | 6 | 10 | 16 |
| 2021 Febrero | 10 | 7 | 17 |
| 2021 Enero | 6 | 7 | 13 |
| 2020 Diciembre | 6 | 7 | 13 |
| 2020 Noviembre | 5 | 3 | 8 |
| 2020 Octubre | 7 | 6 | 13 |
| 2020 Septiembre | 4 | 8 | 12 |
| 2020 Agosto | 7 | 4 | 11 |
| 2020 Julio | 4 | 1 | 5 |
| 2020 Junio | 3 | 2 | 5 |
| 2020 Mayo | 11 | 7 | 18 |
| 2020 Abril | 9 | 4 | 13 |
| 2020 Marzo | 11 | 6 | 17 |
| 2020 Febrero | 12 | 12 | 24 |
| 2020 Enero | 8 | 10 | 18 |
| 2019 Diciembre | 12 | 11 | 23 |
| 2019 Noviembre | 8 | 6 | 14 |
| 2019 Octubre | 4 | 9 | 13 |
| 2019 Septiembre | 4 | 6 | 10 |
| 2019 Agosto | 7 | 11 | 18 |
| 2019 Julio | 7 | 9 | 16 |
| 2019 Junio | 20 | 41 | 61 |
| 2019 Mayo | 58 | 112 | 170 |
| 2019 Abril | 36 | 50 | 86 |
| 2019 Marzo | 6 | 10 | 16 |
| 2019 Febrero | 7 | 10 | 17 |
| 2019 Enero | 6 | 3 | 9 |
| 2018 Diciembre | 12 | 9 | 21 |
| 2018 Noviembre | 15 | 5 | 20 |
| 2018 Octubre | 5 | 3 | 8 |
| 2018 Septiembre | 6 | 5 | 11 |
| 2018 Agosto | 3 | 14 | 17 |
| 2018 Julio | 7 | 6 | 13 |
| 2018 Junio | 6 | 5 | 11 |
| 2018 Mayo | 4 | 11 | 15 |
| 2018 Abril | 8 | 8 | 16 |
| 2018 Marzo | 1 | 2 | 3 |
| 2018 Febrero | 4 | 9 | 13 |
| 2018 Enero | 3 | 3 | 6 |
| 2017 Diciembre | 8 | 3 | 11 |
| 2017 Noviembre | 8 | 8 | 16 |
| 2017 Octubre | 6 | 5 | 11 |
| 2017 Septiembre | 3 | 13 | 16 |
| 2017 Agosto | 3 | 3 | 6 |
| 2017 Julio | 7 | 9 | 16 |
| 2017 Junio | 6 | 11 | 17 |
| 2017 Mayo | 12 | 4 | 16 |
| 2017 Abril | 10 | 12 | 22 |
| 2017 Marzo | 10 | 18 | 28 |
| 2017 Febrero | 11 | 1 | 12 |
| 2017 Enero | 12 | 3 | 15 |
| 2016 Diciembre | 17 | 3 | 20 |
| 2016 Noviembre | 21 | 5 | 26 |
| 2016 Octubre | 31 | 7 | 38 |
| 2016 Septiembre | 33 | 11 | 44 |
| 2016 Agosto | 27 | 1 | 28 |
| 2016 Julio | 10 | 3 | 13 |
| 2016 Junio | 14 | 19 | 33 |
| 2016 Mayo | 6 | 9 | 15 |
| 2016 Abril | 21 | 6 | 27 |
| 2016 Marzo | 11 | 3 | 14 |
| 2016 Febrero | 9 | 10 | 19 |
| 2016 Enero | 6 | 7 | 13 |
| 2015 Diciembre | 17 | 9 | 26 |
| 2015 Noviembre | 16 | 6 | 22 |
| 2015 Octubre | 20 | 7 | 27 |
| 2015 Septiembre | 25 | 5 | 30 |
| 2015 Agosto | 20 | 6 | 26 |
| 2015 Julio | 14 | 5 | 19 |
| 2015 Junio | 4 | 2 | 6 |
| 2015 Mayo | 9 | 6 | 15 |
| 2015 Abril | 14 | 6 | 20 |
| 2015 Marzo | 13 | 5 | 18 |
| 2015 Febrero | 34 | 2 | 36 |
| 2015 Enero | 24 | 4 | 28 |
| 2014 Diciembre | 18 | 6 | 24 |
| 2014 Noviembre | 15 | 3 | 18 |
| 2014 Octubre | 28 | 2 | 30 |
| 2014 Septiembre | 29 | 1 | 30 |
| 2014 Agosto | 25 | 2 | 27 |
| 2014 Julio | 27 | 2 | 29 |
| 2014 Junio | 16 | 3 | 19 |
| 2014 Mayo | 22 | 2 | 24 |
| 2014 Abril | 15 | 2 | 17 |
| 2014 Marzo | 19 | 1 | 20 |
| 2014 Febrero | 15 | 1 | 16 |
| 2014 Enero | 17 | 1 | 18 |
| 2013 Diciembre | 18 | 6 | 24 |
| 2013 Noviembre | 25 | 2 | 27 |
| 2013 Octubre | 14 | 3 | 17 |
| 2013 Septiembre | 13 | 2 | 15 |
| 2013 Agosto | 19 | 5 | 24 |
| 2013 Julio | 23 | 2 | 25 |
| 2009 Diciembre | 364 | 0 | 364 |
Mostrar todo
